Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4222731 | Clinical Imaging | 2013 | 7 Pages |
Abstract
ObjectiveAssess the impact of FDG-PET or PET/CT (PI) on pancreatic cancer management when added to CT or MRI (CDI).Materials and MethodsForty-nine patients underwent 79 PI exams. Discordant findings on PI and CDI were assessed for clinical impact.ResultsFifteen of 79 PI-CDI pairs were discordant. Ten of 79 PI favorably and 5 of 79 unfavorably altered management. PI favorably altered management more often when ordered for therapy monitoring compared to staging [risk ratio 13.00 (95% CI 1.77–95.30)] or restaging [risk ratio 18.5 (95% CI 2.50–137.22)].ConclusionPI favorably alters management more often when used for therapy monitoring compared to staging or restaging.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Omar Javery, Paul Shyn, Koenraad Mortele,